TCL Healthcare and Eckert & Ziegler BEBIG form joint venture for brachytherapy in China

TCL Healthcare Equipment (Shanghai) and Eckert & Ziegler BEBIG signed a joint venture agreement to develop, manufacture, and distribute HDR afterloaders for brachytherapy in China. The JV, TCL Eckert & Ziegler BEBIG Healthcare (Wuxi), is 51% owned by TCL and 49% by Eckert & Ziegler.

“The parties will develop, manufacture and distribute an HDR afterloader for the Chinese market.”haocapital.net

• 1 source
• haocapital.netTCL Healthcare enters the High Dose Rate Brachytherapy solutions market in China - HAO CapitalAnthony HopsonJul 31, 2019

Summarized from public sources; check the original articles before acting on it.